Relationship Science aggregates deep and verified information on over 6 million influential decision makers and the over 1.5 million organizations with which they are associated. From this data, we create a "business social graph" that highlights who knows whom. Here are Matthew Vander Heiden's strongest connections.
People Most Closely Connected to Matthew Vander Heiden
Click the names below to expand relationship details.
Associate Physician, Medicine-Hematology & Oncology at The Massachusetts General Hospital
Daniel Von Hoff
Co-Founder at Cylene Pharmaceuticals, Inc.
Arthur E. Frankel
Leader of Phase 1 Clinical Trials at The University of Texas - Southwestern Medical Center - Harold Simmons Comprehensive Cancer Center
Member, Scientific Advisory Board at Celsee Diagnostics
Co-Founder at Aeglea BioTherapeutics, Inc.
Anthony G. Quinn
Chief Executive Officer & Director at Aeglea BioTherapeutics, Inc.
Suzanne L. Bruhn
President & Chief Executive Officer at Proclara Biosciences, Inc.
James D. Griffin
Chair, Division of Medical Oncology at The Brigham & Women's Hospital, Inc.
Jay R. Harris
Chair, Department of Radiation Oncology at Dana-Farber Cancer Institute, Inc.
Barrett J. Rollins
Chief Scientific Officer at Dana-Farber Cancer Institute, Inc.
Craig A. Bunnell
Chief Medical Officer & Medical Director for Adult Ambulatory Oncology at Dana-Farber Cancer Institute, Inc.
Susan D. Block
Chair, Department of Psychosocial Oncology & Palliative Care at The Brigham & Women's Hospital, Inc.
Annick D. Van Den Abbeel
Chief, Department of Imaging at Dana-Farber Cancer Institute, Inc.
Robert J. Soiffer
Chief, Hematologic Malignancies at Dana-Farber Cancer Institute, Inc.
Professor at Dana-Farber Cancer Institute, Inc.
Eric P. Winer
Chief, Division of Women's Cancers at Dana-Farber Cancer Institute, Inc.
Joseph O. Jacobson
Chief Quality Officer at Dana-Farber Cancer Institute, Inc.
Chief, Division of Adult Hematology at Dana-Farber Cancer Institute, Inc.
There are 1,012 more people accessible only with RelSci Professional.